Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HZ/su vaccine in adult renal transplant recipients
2012-005059-18Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2013
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in herpes zoster (HZ) comparing Shingrix with Placebo (2 arms). Primary endpoint: Vaccine response rate for anti-gE humoral immune response at Month 2. Started Apr 2013; status: completed.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on 2012-005059-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005059-18.